Estimating vaccine effectiveness against SARS-CoV-2 infection, hospitalization and death from ecologic data in Costa Rica
Abstract Background Clinical trials and individual-level observational data in Israel demonstrated approximately 95% effectiveness of mRNA-based vaccines against symptomatic SARS-CoV-2 infection. Individual-level data are not available in many countries, particularly low- and middle- income countrie...
Main Authors: | Romain Fantin, Rolando Herrero, Allan Hildesheim, Cristina Barboza-Solís, Amada Aparicio, D. Rebecca Prevots, Ruth M. Pfeiffer, Mitchell H. Gail, the RESPIRA Study Group |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-10-01
|
Series: | BMC Infectious Diseases |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12879-022-07740-5 |
Similar Items
-
Excess mortality from COVID 19 in Costa Rica: a registry based study using Poisson regressionResearch in context
by: Romain Fantin, et al.
Published: (2023-04-01) -
Behavioral factors and SARS-CoV-2 transmission heterogeneity within a household cohort in Costa Rica
by: Kaiyuan Sun, et al.
Published: (2023-07-01) -
Cohort profile: evaluation of immune response and household transmission of SARS-CoV-2 in Costa Rica: the RESPIRA study
by: Allan Hildesheim, et al.
Published: (2023-12-01) -
Estimating the cumulative incidence of SARS-CoV-2 infection in Costa Rica: modelling seroprevalence data in a population-based cohortResearch in context
by: Romain Fantin, et al.
Published: (2023-11-01) -
Health inequalities in cause-specific mortality in Costa Rica: a population-based cohort study
by: Romain Fantin, et al.
Published: (2023-02-01)